Aug 9, 2019, 01:00 by admin admin

The American Society of Addiction Medicine is pleased to hear that The ASAM Criteria was included in today’s discussion about solutions to combat the opioid misuse and overdose crisis. Addressing this public health emergency will require systemic and sustainable changes to our addiction treatment infrastructure and workforce, as well as expanded access to comprehensive, evidenced-based treatment that includes all levels of care. 

Aug 9, 2019, 01:00 by admin admin

ASAM sent letters of support for the Removing Barriers to Medicaid and CHIP Addiction Treatment Act and the Medicaid Coverage for Addiction Recovery Treatment Act. These bills would work to repeal Medicaid Institutions for the Mental Diseases (IMD) exclusion for mental health and substance use disorder residential treatment facilities. 

Aug 9, 2019, 01:00 by admin admin

On May 16, the Food and Drug Administration (FDA) announced its approval Lucemyra, the first non-opioid treatment for management of opioid withdrawal symptoms. Lucemyra (lofexidine hydrochloride) reduces the release of norepinephrine and can be used to lessen the severity of withdrawal symptoms that may occur after the discontinuation of opioid use.

Aug 9, 2019, 01:00 by admin admin

Updated definition of addiction to explain more fully the complexity of this chronic disease with the intent of driving a bold and comprehensive national response.

Aug 9, 2019, 01:00 by admin admin

Today the American Society of Addiction Medicine (ASAM) submitted a letter to the House Committee on Energy and Commerce as it considers legislation to address the opioid misuse, addiction, and overdose epidemic. The letter, submitted to Chairman Greg Walden (R-OR) and Ranking Member Frank Pallone (D-NJ), urges the Committee to approve bills that expand the provision of evidence-based treatment, strengthen America’s addiction treatment infrastructure, and bolster the nation’s addiction treatment workforce.

Aug 9, 2019, 01:00 by admin admin

The Partnership to Amend 42 CFR Part 2 sent a letter urging Senator Lamar Alexander to use the Lower Health Care Costs Act of 2019 as an opportunity to align 42 CFR Part 2 with HIPAA.

Aug 9, 2019, 01:00 by admin admin

Dr. Shawn Ryan appeared before the Kentucky House Committee on Banking and Insurance in support of HB389.

Aug 9, 2019, 01:00 by admin admin

Yngvild Olsen, MD, MPH urged lawmakers to expand access to evidence-based addiction treatment and invest more resources to address the addiction and overdose crisis during today’s House Committee on Oversight and Reform Hearing .

Aug 9, 2019, 01:00 by admin admin

Dr. Kelly J. Clark, president of ASAM, participated in a congressional roundtable sponsored by the House Bipartisan Heroin and Opioid Task Force. At the event, she urged lawmakers to make strategic investments in the substance use disorder (SUD) treatment workforce in order to close the addiction treatment gap and ensure the millions of Americans living with SUD are able to receive the care they need.

Aug 9, 2019, 01:00 by admin admin

The Coalition to Stop Opioid Overdose (CSOO) is proud to announce A New PATH (Parents for Addiction Treatment and Healing) as a new member of the coalition. A New PATH works with families, individuals in recovery, healthcare professionals and community leaders to reduce the stigma associated with addictive illness through education and compassionate support and to advocate for therapeutic rather than punitive drug policies.

Jul 19, 2019, 01:00 by admin admin

Friends of HRSA sent a letter to legislators urging them to appropriate $8.8 billion for discretionary Health Resources and Services Administration programs for FY2021.

Jul 19, 2019, 01:00 by admin admin

ASAM applauds the introduction of the Cannabidiol and Marijuana Research Expansion Act, which would enable researchers to better study cannabis.

Jul 19, 2019, 01:00 by admin admin

ASAM supports the introduction of the Medical Marijuana Research Act, which would enable researchers to better study cannabis.

Jun 10, 2019, 01:00 by admin admin

ASAM signed onto a letter commenting on the Tobacco to 21 Act, the Reversing the Youth Tobacco Epidemic Act, and the Stopping Consumption of Tobacco by Teens (SCOTT) Act of 2019.

May 8, 2019, 01:00 by admin admin

ASAM commended Senator Elizabeth Warren, Representatives Elijah Cummings, and all original co-sponsors for introducing the CARE Act of 2019. Modeled on successful, bipartisan legislation passed in 1990 to address the HIV/AIDS epidemic, the CARE Act would authorize $100 billion in federal funding over the next decade to states, local governments, and other organizations and institutions to support substance use disorder treatment programs, improve training for addiction treatment professionals in communities across the US, and expand access to treatments that meet national standards and are proven to save lives. 

May 6, 2019, 01:00 by admin admin

ASAM joins over 75 organizations, including the Association of American Medical Colleges, in sending a letter urging members of Congress to cosponsor The Resident Physician Shortage Reduction Act of 2019 (S.348, H.R. 1763).

Apr 25, 2019, 01:00 by admin admin

ASAM today commended a bipartisan group of US Senators calling for strategic investments to increase the ranks of qualified, well-trained addiction treatment professionals in high-need communities across the United States.

Apr 11, 2019, 01:00 by admin admin

On April 3, the Board of Directors of the American Society of Addiction Medicine (ASAM) approved a new policy statement: Public Policy Statement on the Ethical Use of Drug Testing in the Practice of Addiction Medicine. This Policy Statement includes recommendations on the clinical use of drug testing, appropriateness of presumptive testing, and the responsibilities of clinicians when testing for drugs.

Apr 9, 2019, 01:00 by admin admin

ASAM joined 18 other organizations in sending a letter urging the leadership of the House Appropriations Subcommittee on Labor, Health & Human Services, Education, and Related Agencies to fund programs in the Health Resources and Services Administration’s (HRSA) “Public Health and Preventive Medicine” line item in Fiscal Year 2020 (FY20) at the level of $24 million.

Apr 4, 2019, 01:00 by admin admin

An analysis of the impact of a federal judge's rulings striking down Medicaid work requirement programs in Kentucky and Arkansas.